e-learning
resources
Breathe
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acquisition and eradication of P. aeruginosa in young children with CF
P. Merkus
Source:
Breathe 2009; 5: 358
Journal Issue:
June
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Merkus. Acquisition and eradication of P. aeruginosa in young children with CF. Breathe 2009; 5: 358
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Respiratory sequelae of preterm birth across the life span
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
Source: Eur Respir J 2009; 33: 305-311
Year: 2009
Newly acquired
pseudomonas aeruginosa
in Belgian cystic fibrosis-patients: does the patients‘
P. aeruginosa
genotype correlate with environmental genotypes?
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006
Prevalence of
pseudomonas aeruginosa
in pancreatic sufficient CF patients in Scandinavia
Source: Eur Respir J 2006; 28: Suppl. 50, 714s
Year: 2006
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006
Omics-based tracking of
Pseudomonas aeruginosa
persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Pseudomonas aeruginosa
in patients with cystic fibrosis - a comparison of early eradication and conventional therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017
Comparative in vitro activity of fluoroquinolones against P. aeruginosa isolated from Greek CF patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020
Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with
Pseudomonas aeruginosa
Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016
Year: 2017
Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis
Source: Eur Respir J , 49 (4) 1600851; DOI: 10.1183/13993003.00851-2016
Year: 2017
Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017
Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006
Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006
Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis.
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept